For my Leadership and Transition course our final project is a mock trial. The case I have to argue involves a nurse being sued after the catheter became dislodged during a Mytomycin infusion. The nurse was found not liable as she followed policy and protocol during the infusion and after the suspected extravasation.
My question is that the nurse started the IV in the patient's hand, and most of the research I've done states the forearm should be used instead. I have to argue on behalf of the nurse. Does anyone know the reasoning behind starting in the hand? The reasoning I came up with is that the patient was 40 with no significant PMH (we really don't get a lot of info to go off of), so fragile veins may not be a concern. Additionally, if there was a problem with the infusion starting distal lot offers more options to move the IV.
Any thoughts?
Thanks!!
Featured Replies
Join the conversation
You can post now and register later.
If you have an account, sign in now to post with your account.
Hi All,
For my Leadership and Transition course our final project is a mock trial. The case I have to argue involves a nurse being sued after the catheter became dislodged during a Mytomycin infusion. The nurse was found not liable as she followed policy and protocol during the infusion and after the suspected extravasation.
My question is that the nurse started the IV in the patient's hand, and most of the research I've done states the forearm should be used instead. I have to argue on behalf of the nurse. Does anyone know the reasoning behind starting in the hand? The reasoning I came up with is that the patient was 40 with no significant PMH (we really don't get a lot of info to go off of), so fragile veins may not be a concern. Additionally, if there was a problem with the infusion starting distal lot offers more options to move the IV.
Any thoughts?
Thanks!!